Nimotuzumab (Anti-ERBB1 / EGFR / HER1)

Nimotuzumab (Anti-ERBB1 / EGFR / HER1) is a humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. MW: 147.58 KD.

• Supplier: Selleck Chemicals
• Product #: A2944
• Sku #: A2944-1mg*25